Home » Topics » Regulatory

Regulatory
RSS

FDA approves sNDA for rufinamide in Lennox-Gastaut syndrome in children aged 1-4 years

Feb. 16, 2015

FDA approves lenvatinib for thyroid cancer

Feb. 16, 2015

CrystalGenomics' polmacoxib approved in South Korea for osteoarthritis

Feb. 9, 2015

FDA grants accelerated approval for Ibrance in advanced breast cancer

Feb. 4, 2015

FDA approves Glyxambi for type 2 diabetes

Feb. 3, 2015

FDA approves first drug for Waldenstrom's macroglobulinemia

Feb. 2, 2015

FDA approves Vyvanse for binge eating disorder

Feb. 2, 2015

FDA approves Bristol-Myers Squibb's Evotaz for HIV-1 infection

Jan. 30, 2015

FDA approves Triferic for iron replacement and hemoglobin maintenance in CKD

Jan. 27, 2015

FDA approves Natpara for treatment of hypocalcemia in patients with hypoparathyroidism

Jan. 27, 2015

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 4, 2026.
University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...
Alceptor Therapeutics discovers new α2B-adrenoceptor agonists
BioWorld Science
Alceptor Therapeutics Inc. has patented new pyrazol-5-amine α2B-adrenoceptor agonists reported to be useful for the treatment of pain and hypertension.
EQ-504 is AhR agonist for ulcerative colitis, related disorders
BioWorld Science
Activating the aryl hydrocarbon receptor (AhR) in immune cells enhances anti-inflammatory pathways and limits pathogenic immune responses. Equillium Inc. has...
Quintuple GLP-1–GIP–PPAR agonist for obesity and diabetes control
BioWorld
A new molecule combines the action of two incretins, GLP-1 and GIP, hormones that regulate glucose and appetite, with lanifibranor, a triple agonist of peroxisome...